Journal of Immunization invites high quality submissions that advance vaccine science, immunization program delivery, and population protection. We welcome original research, systematic reviews, implementation studies, and policy analyses that improve vaccination outcomes.

Our editorial focus prioritizes rigorous study design, transparent reporting, and practical insights for immunization programs in diverse settings.

We encourage submissions that connect immunologic discovery with real world program outcomes. Studies that examine vaccine performance across settings, populations, and delivery models are especially valuable for decision makers.

Priority themes include vaccine development, immunogenicity, safety monitoring, delivery systems, and policy evaluation. Authors should highlight how findings inform coverage gains, safety assurance, or equity improvement.

• Vaccine development, formulation, and adjuvant innovation
• Immunogenicity, correlates of protection, and durability
• Safety surveillance, adverse event monitoring, and risk communication
• Vaccine effectiveness in real world settings
• Cold chain, delivery systems, and implementation logistics
• Equity, access, and community uptake strategies
• Maternal, pediatric, and adult immunization programs
• Emerging infections and outbreak response vaccination
• Health economics and immunization policy evaluation

We also welcome brief reports that present urgent safety updates, policy analyses grounded in data, and methodological notes that improve surveillance or immunogenicity measurement. Submissions should provide clear context and relevance for immunization stakeholders.

• Clinical trial reports and immunogenicity analyses
• Surveillance or registry studies with clear methods
• Policy briefs grounded in data
• Technical notes on delivery or cold chain systems

Strong submissions present a clear public health question, robust methodology, and transparent reporting of outcomes and limitations. We value studies that connect immunologic findings to program decisions.

Authors should document population characteristics, vaccination schedules, and outcome definitions to support reproducibility and program relevance.

• Clear inclusion criteria and population context
• Validated endpoints and outcome definitions
• Appropriate statistical analysis and confounder control
• Interpretation aligned with program or policy decisions

Immunization programs require evidence that is actionable for clinicians, managers, and policymakers. We value studies that demonstrate how findings can improve delivery design, service integration, or risk communication.

When reporting program evaluations, describe implementation context, resource constraints, and operational changes that may affect outcomes. This detail helps program teams translate evidence into local action.

Submissions that examine trust, demand generation, and community partnership are important for improving vaccination uptake. Authors should document engagement methods and equity considerations, especially in settings with historical access barriers.

We encourage analyses that capture gender, age, geography, and socioeconomic factors that influence immunization coverage. Clear reporting of equity indicators supports decision making and accountability.

Submissions undergo editorial screening for scope fit, ethics compliance, and reporting completeness. Qualified manuscripts move to single blind peer review with subject matter experts.

JI operates under an open access model to ensure immunization evidence is discoverable and reusable. APCs are applied after acceptance and support peer review, production, and archiving services.

Membership options and affordable APC waivers are available for eligible authors. Contact the editorial office at [email protected] for guidance.

Authors may submit via ManuscriptZone (https://oap.manuscriptzone.net) for full tracking and reviewer communication, or use the Simple Manuscript Submission Form (https://openaccesspub.org/manuscript-submission-form) for a streamlined entry. Both routes receive the same editorial screening and peer review standards.

Pre submission questions are welcome. Authors may share a short summary to confirm scope fit or article type.

After submission, the editorial office provides status updates during screening and review to keep decisions on track.

Timely communication helps authors plan revisions and reporting timelines.

Clear responses to editorial queries help avoid delays in final decisions.

Immunization science connects laboratory discovery, clinical evaluation, and population health. The journal values studies that link immunologic mechanisms to real world impact, including coverage gains, reduced disease burden, and improved equity.

We encourage submissions that integrate evidence across clinical trials, surveillance systems, and implementation programs. Clear descriptions of study settings, population risk profiles, and delivery constraints help readers translate findings into action.

Public health decisions depend on evidence that is timely, reproducible, and interpretable for policy teams. Authors should describe how findings inform program design, supply planning, or risk communication strategies.

For studies that evaluate immunization coverage or uptake, report data sources, measurement intervals, and equity considerations. Evidence that accounts for operational realities is especially valuable to decision makers.

Immunization studies often rely on surveillance systems, registries, or administrative datasets. Clearly document case definitions, outcome adjudication, and data cleaning steps to support reproducibility.

For vaccine safety research, describe adverse event monitoring, attribution methods, and reporting timelines. Transparent statistical approaches and sensitivity analyses strengthen confidence in results.

Include a cover letter that highlights novelty, policy relevance, and data sources. If your study involves public health surveillance or registries, summarize governance approvals and data access permissions.

For vaccine trials, list registration identifiers and protocol deviations clearly to avoid delays in screening.

If your work involves community engagement or demand generation, summarize how participants were informed and how equity considerations were addressed.

JI is committed to rigorous, transparent publishing in immunization research and program evaluation. We emphasize reproducible methods, clear reporting of vaccine outcomes, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in vaccine science, safety monitoring, and public health impact.